A detailed history of Brevan Howard Capital Management LP transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 10,780 shares of EYPT stock, worth $98,852. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,780
Previous 13,561 20.51%
Holding current value
$98,852
Previous $117,000 26.5%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.58 - $10.54 $21,079 - $29,311
-2,781 Reduced 20.51%
10,780 $86,000
Q2 2024

Aug 14, 2024

BUY
$8.16 - $22.89 $110,657 - $310,411
13,561 New
13,561 $117,000

Others Institutions Holding EYPT

About EyePoint Pharmaceuticals, Inc.


  • Ticker EYPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,072,200
  • Market Cap $312M
  • Description
  • EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...
More about EYPT
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.